January 08, 2020
Michael Byrne, D.O., is an assistant professor of medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center, specializing in stem cell transplantation. His research focuses on improving the outcomes of patients with high-grade myeloid neoplasms after allogeneic hematopoietic cell transplantation.